# Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

> **NCT00803907** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 20 (estimated)

## Conditions studied

- Carcinoma, Basal Cell

## Interventions

- **DRUG:** Imiquimod 5% cream

## Key facts

- **NCT ID:** NCT00803907
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2012-09
- **Final completion:** 2013-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00803907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00803907, "Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00803907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*